Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Doravirine 100 Mg
DRUG
2 trials
Sponsors
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
, University of Texas Southwestern Medical Center
Conditions
Cardiovascular Risk Factor
HIV I Infection
HIV Infections
Lipid Metabolism Disorders
Early Phase 1
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Completed
NCT04820933
University of Texas Southwestern Medical Center
Cardiovascular Risk Factor, HIV I Infection, Lipid Metabolism Disorders
Start: 2024-03-01
End: 2025-12-01
Updated: 2026-01-30
Phase 4
Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide
Completed
NCT04636437
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
HIV Infections
Start: 2021-07-27
End: 2024-10-18
Updated: 2025-07-02
Related Papers
A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).
2026-03-18
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor–Based Regimen Switch Strategy to Manage Integrase Inhibitor–Related Weight Gain
Clinical Infectious Diseases
2024-09-04
9 citations